Abbvie Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 2.27 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.15 Cr
as on 16-11-2024
- Company Age 16 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 35.72%
(FY 2023)
- Profit -24.09%
(FY 2023)
- Ebitda 38.71%
(FY 2023)
- Net Worth 21.92%
(FY 2023)
- Total Assets 22.95%
(FY 2023)
About Abbvie Healthcare India
The Corporate was formerly known as Allergan Healthcare India Private Limited. The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.27 Cr and a paid-up capital of Rs 2.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vidhan Kedia, Hong Shi, Kesavan Gopinath, and One other member serve as directors at the Company.
- CIN/LLPIN
U85190KA2008PTC048318
- Company No.
048318
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Nov 2008
- Date of AGM
14 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Abbvie Healthcare India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vidhan Kedia  | Director | 25-Jan-2023 | Current |
Hong Shi  | Director | 01-Feb-2024 | Current |
| Kesavan Gopinath | Director | 14-Sep-2023 | Current |
| Suresh Pattathil | Director | 25-Aug-2022 | Current |
Financial Performance and Corporate Structure Insights of Abbvie Healthcare India.
Abbvie Healthcare India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 35.72% increase. The company also saw a substantial fall in profitability, with a 24.09% decrease in profit. The company's net worth Soared by an impressive increase of 21.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abbvie Healthcare India?
In 2023, Abbvie Healthcare India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Organisation Of Pharmaceutical Producers Of IndiaActive 58 years 11 monthsSuresh Pattathil is a mutual person
Abbvie Therapeutics India Private LimitedActive 30 years 5 monthsVidhan Kedia, Hong Shi and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Abbvie Healthcare India?
Abbvie Healthcare India has a workforce of 157 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abbvie Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abbvie Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
